| 前收市價 | 3.4100 |
| 開市 | 3.4800 |
| 買盤 | 3.4000 x 100 |
| 賣出價 | 0.0000 x 0 |
| 今日波幅 | 3.3400 - 3.5300 |
| 52 週波幅 | 1.9500 - 3.8700 |
| 成交量 | |
| 平均成交量 | 14,819 |
| 市值 | 28.867M |
| Beta 值 (5 年，每月) | 1.13 |
| 市盈率 (最近 12 個月) | 無 |
| 每股盈利 (最近 12 個月) | -2.4600 |
| 業績公佈日 | 2024年8月12日 - 2024年8月16日 |
| 遠期股息及收益率 | 無 (無) |
| 除息日 | 無 |
| 1 年預測目標價 | 14.50 |
Insider MonkeyLisata Therapeutics, Inc. (NASDAQ:LSTA) Q1 2024 Earnings Call Transcript
Lisata Therapeutics, Inc. (NASDAQ:LSTA) Q1 2024 Earnings Call Transcript May 9, 2024 Lisata Therapeutics, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Welcome to the Lisata Therapeutics First Quarter 2024 Financial Results and Business Update Conference Call. At this […]
ZacksLisata's (LSTA) LSTA1 Gets FDA Orphan Drug Tag for Osteosarcoma
The FDA bestows an Orphan Drug designation to Lisata's (LSTA) lead investigational product candidate, LSTA1, for the treatment of osteosarcoma. Stock rises.
- Zacks
Lisata's (LSTA) LSTA1 Gets FDA's RPDD Tag for Osteosarcoma
Lisata's (LSTA) lead investigational product candidate, LSTA1, gets Rare Pediatric Disease Designation for treating osteosarcoma. Stock rises.
